MedTrace Logo

Ketorolac Premedication for Anesthetic Efficiency of IANB & Postendodontic Pain in Teeth With Irreversible Pulpitis

NCT02940405 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2016-10-21

No results posted yet for this study

Summary

The aim of this study to assess effect of ketorolac premedication on the effectiveness of the inferior alveolar nerve block, pretreatment and postoperative pain in patients with symptomatic irreversible pulpitis.

Conditions

  • Irreversible Pulpitis

Interventions

DRUG

Ketorolac Tromethamine

A 10 mg tablet of the medication will be given one hour before starting the root canal treatment

DRUG

Placebo

The placebo given as a tablet one hour before staring the root canal treatment

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Laila Z Ismail, Postgraduate · Cairo University

  • Suzan AW Amin, PhD · Cairo University

  • Salsabeel M Ibrahim, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-10-31
Completion
2018-01-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02940405 on ClinicalTrials.gov